Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”
In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires
PCI Files Application For Research Base COP
Eight applications Received For NSABP chairman
Pitt Criticizes NCI Stance On Repayment For Fraud Trials
Broder, Herberman, Decline To Coauthor Reanalysis of Data
“I Can’t Permit Destruction of NSABP,” Fisher Writes
Herberman: Progress Made To Stabilize NSABP
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya